UnknownPhase 3NCT03051490
RESULT: Reliable, Emergent Solution Using Liprotamase Treatment
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Anthera Pharmaceuticals
- Principal Investigator
- Monica GangalAnthera Pharmaceuticals
- Intervention
- Liprotamase(drug)
- Enrollment
- 140 enrolled
- Eligibility
- 7 years · All sexes
- Timeline
- 2017 – 2018
Study locations (30)
- Investigator Site 139, Little Rock, Arkansas, United States
- Investigator Site #123, Long Beach, California, United States
- Investigator Site 107, Los Angeles, California, United States
- Investigator Site 143, Orange, California, United States
- Investigator Site 150, Denver, Colorado, United States
- Investigator Site 147, Wilmington, Delaware, United States
- Investigator Site 117, Altamonte Springs, Florida, United States
- Investigator Site 102, Jacksonville, Florida, United States
- Investigator Site 130, Miami, Florida, United States
- Investigator Site 151, West Palm Beach, Florida, United States
- Investigator Site 110, Atlanta, Georgia, United States
- Investigator Site 109, Glenview, Illinois, United States
- Investigator Site 148, Iowa City, Iowa, United States
- Investigator Site #122, Louisville, Kentucky, United States
- Investigator Site 132, Portland, Maine, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03051490 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.